Genetic Signatures to increase European Market presence at ECCMID 2013
Genetic Signatures will increase its European Market presence at the 23rd European Congress of Clinical Microbiology and Infectious Diseases, which will be held in Berlin from 27 to 30 April 2013. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection of infectious disease including kits for diagnosing bacterial, viral and protazoan causes of…
Read MoreGenetic Signatures at MMM2013
The Molecular Microbiology Meeting 2013 (MMM2013) will be held on 6-7 March at WatervieW in Bicentennial Park, Sydney NSW Australia. MMM provides a forum for research scientists, laboratory staff and clinicians to share the latest issues and developments in the field of molecular microbiology. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection…
Read MoreGenetic Signatures receives CE mark for EasyScreen™ Enteric Protozoan Detection Kit
Following on from the CE-IVD approval of the EasyScreen™ C. difficile kits Genetic Signatures has received the CE mark for it’s EasyScreen™ Enteric Protozoan Detection Kit. The EasyScreen™ Protozoan Detection Kit is a real-time PCR kit for the detection of Entamoeba, Dientamoeba, Cryptosporidium, Giardia and Blastocystis. The multiplexed real-time PCR is performed over two wells and includes an…
Read MoreGenetic Signatures receives CE mark for EasyScreen™ C. difficile Reflex Assay
Genetic Signatures is pleased to announce that it has gained the European CE-IVD Mark for its EasyScreen™ C. difficile Reflex Kit. The real-time multiplex PCR assay can be used directly from patient stool samples and yields a result in approximately 3 hours. The EasyScreen™ C. difficile Reflex kit detects the more dangerous hypervirulent forms of…
Read MoreGenetic Signatures to present poster & exhibit at ASM2012
Genetic Signatures will be presenting a poster and exhibiting at ASM 2012 in Brisbane from 1- 4 July 2012. The poster presented by S.P. Siah and K. Kaur (Research Scientists Genetic Signatures) will describe the development of a complete screening system for the diagnosis of all major gastrointestinal pathogens from primary clinical samples. The EasyScreen assays…
Read MoreGenetic Signatures launches new EasyScreen™ product range at ECCMID2012
Genetic Signatures has launched a new EasyScreen™ product range at the 22nd European Congress of Clinical Microbiology and Infectious Diseases in London from 31st March to 3rd April 2012. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. Dr John Melki has presented a poster outlining the…
Read MoreGenetic Signatures launches EasyScreen™ kits for the detection of Enteric Pathogens
Genetic Signatures is pleased to announce the launch of EasyScreen kits for the detection of Enteric Pathogens. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. A universal sample preparation method allows for rapid efficient (automatable) nucleic acid isolation. Existing nucleic acid isolation and real-time PCR platforms can be utilized,…
Read MoreGenetic Signatures receives CE mark for EasyScreen™ C. difficile Detection Assay
Genetic Signatures is pleased to announce that it has gained the European CE-IVD Mark for its EasyScreen™ C. difficile Detection Kit. The real-time multiplex PCR assay can be used directly from patient stool samples and yields a result in approximately 3 hours. The CE-IVD approval paves the way for CE-IVD marking of the EasyScreen™ C.…
Read More